These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33501369)

  • 1. Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies.
    Lau CS; Hoo SP; Liang YL; Phua SK; Aw TC
    Pract Lab Med; 2021 Mar; 24():e00201. PubMed ID: 33501369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays.
    Cs L; Sp H; Yl L; Sk P; Tc A
    Pract Lab Med; 2021 May; 25():e00230. PubMed ID: 33937471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays.
    Lau CS; Wong MS; Hoo SP; Heng PY; Phua SK; Aw TC
    Pract Lab Med; 2021 Nov; 27():e00257. PubMed ID: 34660869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
    Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
    Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    Harley K; Gunsolus IL
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
    Charlton CL; Kanji JN; Johal K; Bailey A; Plitt SS; MacDonald C; Kunst A; Buss E; Burnes LE; Fonseca K; Berenger BM; Schnabl K; Hu J; Stokes W; Zelyas N; Tipples G
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32665420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of an automated chemiluminescence SARS-CoV-2 IG-G assay.
    Lau CS; Oh HML; Hoo SP; Liang YL; Phua SK; Aw TC
    Clin Chim Acta; 2020 Nov; 510():760-766. PubMed ID: 32910979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19.
    Chamkhi S; Dhaouadi T; Sfar I; Mokni S; Jebri A; Mansouri D; Ghedira S; Ben Jemia E; Ben Boujemaa S; Houissa M; Aouina H; Ben Abdallah T; Gorgi Y
    Int J Immunopathol Pharmacol; 2022; 36():20587384211073232. PubMed ID: 35113728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples.
    Hanssen DAT; Slaats M; Mulder M; Savelkoul PHM; van Loo IHM
    Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1695-1703. PubMed ID: 33733395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2.
    Cerino P; Gallo A; Pierri B; Buonerba C; Di Concilio D; Cuomo MC; Vassallo L; Lo Conte G; Coppola A; Pizzolante A; Boccia G; Ferrucci V; Atripaldi L; Triassi M; Pacella D; Cennamo M; Romano P; Sorbo TM; Furno A; Catapano O; Contina A; Perruolo G; D'Amora M; Terracciano D; Portella G
    Front Public Health; 2021; 9():649781. PubMed ID: 33996728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers.
    Mitani A; Horie T; Yokoyama R; Nakano Y; Hamada K; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Usui T; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Iwasawa K; Yao A; Kurano M; Yatomi Y; Yanagimoto S
    J Infect Chemother; 2022 Feb; 28(2):266-272. PubMed ID: 34887175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays.
    Poore B; Nerenz RD; Brodis D; Brown CI; Cervinski MA; Hubbard JA
    Clin Biochem; 2021 Sep; 95():77-80. PubMed ID: 34118242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories.
    Plaga A; Wei R; Olson E; Payto D; Harrington J; Nwe-Kissig PT; Strizzi M; Zilka S; Ko J; Colón-Franco JM
    J Appl Lab Med; 2021 Jul; 6(4):998-1004. PubMed ID: 33825844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.